Aytu Biopharma, Inc. (AYTU)
2.29
+0.05
(+2.23%)
USD |
NASDAQ |
May 29, 16:00
2.25
-0.04
(-1.75%)
After-Hours: 20:00
Aytu Biopharma Profit Margin (Quarterly) : -45.27% for March 31, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Talphera, Inc. | -- |
| Aquestive Therapeutics, Inc. | -55.77% |
| ANI Pharmaceuticals, Inc. | 11.55% |
| Corcept Therapeutics, Inc. | -18.92% |
| Assertio Holdings, Inc. | -189.8% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -135.0% |
| Return on Assets | -28.09% |
| Return on Invested Capital | -69.55% |
| Gross Profit Margin (Quarterly) | 55.10% |
| Operating Margin (Quarterly) | -32.75% |
| Return on Net Operating Assets | -37.48% |